Most Recent Articles by Alison Kanski
Celgene's drug will now have time to establish itself in the market without generic competition.
Novartis voluntarily halts price increases; Shkreli's former company considers name change; FDA issues guidance to modernize electronic health data in trials.
Prophet surveyed 240 healthcare organizations to find out where the industry is actually at on its shift to consumer centricity.
Vital Health is driven by Ketchum's new analytics tool, Vital Diagnostics.
Alexa could make it easier for doctors to squeeze CME programs into their busy schedules.